WebThe study suggests that radioimmunotherapy using intravesically instilled (213)Bi-anti-EGFR-mAb is a promising option for treatment of bladder cancer in patients. … WebTo clarify the molecular mechanisms of cell death induction, we investigated the molecular effects of the alpha-emitter Bismuth-213 (Bi-213) bound to a monoclonal anti-CD33-antibody ( [Bi-213]anti-CD33) on the cell cycle and on apoptosis induction in sensitive as well as in beta- and gamma-radiation-resistant CD33-positive acute myeloid leukaemia …
Targeted alpha therapy of mCRPC: Dosimetry estimate of 213 Bismuth …
WebBismuth-213 was the first reported alpha-particle emitter used in a clinical trial as a potential cancer therapeutic. This radionuclide has a half-life of 45.6 min and mostly decays to … Web212 Bi and 213 Bi are considered to be two potential radiometal α emitters suitable for radiotherapy applications. The production modes for 212 Bi and 213 Bi have been recently reviewed. 57,58 212 Bi is the daughter of 212 Pb discussed above, and is available from the same generator system (224 Ra/ 212 Pb). 54–56 212 Bi is a member of the 232 Th … early pregnancy symptoms night sweats
Targeted Radionuclide Therapy - an overview ScienceDirect …
WebJun 1, 2024 · Finally , we provide an overview of preclinical and clinical studies involving 213 Bi-radiopharmaceuticals, as well as the future perspectives of this promising cancer treatment option. View Show ... WebBismuth-213 is one of the isotopes which has been used. This is made by the alpha decay of actinium-225. The generation of one short-lived isotope from longer lived isotope is a useful method of providing a portable supply of a short-lived isotope. This is similar to the generation of technetium-99m by a technetium generator. WebNov 5, 2000 · The isotope bismuth-213 was attached to an antibody designed to carry the alpha-emitting isotope to the cancer. The tests were to see if the treatment did more harm than good in acute myeloid ... early pregnancy symptoms migraine